Clinical Studies and Case Reports

On this site you will find clinical studies with cannabis or single cannabinoids in different diseases and case reports on the use of cannabis by patients.
You may search for diseases (indications), authors, medication, study design (controlled study, open trial, case report etc.) and other criteria.




[Back to Overview]  [IACM Homepage]

TitleDose vs response of tetrahydroannabinol (THC) vs prochlorperazine as chemotherapy antiemetics.
Author(s)Levitt M, Wilson A, Bowman D, Faiman C, Kemel S, Krepart G
Journal, Volume, IssueProceedings of the American Society for Clinical Oncology 1981;22:422
Major outcome(s)THC 15 mg was the most effective against vomiting, prochlorperazine was the most effective antinauseant
IndicationNausea/vomiting;Cancer;Cancer chemotherapyAbstract
MedicationDelta-9-THC

Route(s)Oral
Dose(s)dronabinol either 5, 10 or 15 mg, 2 h before and 2, 6 and 10 h after start of chemotherapy
Duration (days)
Participantspatients receiving antiemetics for first course of chemother
DesignControlled study
Type of publication
Address of author(s)
Full text

[Back to Overview]  [IACM Homepage]


up